Home Applications 202008 Application 202008
Type NDA
Sponsor AVID RADIOPHARMS INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AMYVID FLORBETAPIR F-18 SOLUTION;INTRAVENOUS 10ML (13.5-51mCi/ML) No No 002 AMYVID FLORBETAPIR F-18 SOLUTION;INTRAVENOUS 10-30ML (13.5-51mCi/ML) Yes Yes 003 AMYVID FLORBETAPIR F-18 SOLUTION;INTRAVENOUS 10-50ML (13.5-51mCi/ML) Yes Yes 004 AMYVID FLORBETAPIR F-18 SOLUTION;INTRAVENOUS 10-100ML (13.5-51mCi/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N202008-001 AMYVID FLORBETAPIR F-18 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 N202008-002 AMYVID FLORBETAPIR F-18 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 N202008-003 AMYVID FLORBETAPIR F-18 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 N202008-004 AMYVID FLORBETAPIR F-18 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 157 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 c2088c7a36db…2026-09-14 22:38:34 2026-08 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-001 AMYVID 10ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-002 AMYVID 10-30ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD 2012-04-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-003 AMYVID 10-50ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2012-04-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N202008-004 AMYVID 10-100ML (13.5-51mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-10-13 03ed91905a0d…
Observed Orange Book patent history# Patent history page 1 of 8 · 286 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 c2088c7a36db…2026-09-14 22:38:34 2026-08 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N202008-001 7687052 2027-04-30 U-4217 Drug substance, Drug product 2012-05-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-001 8506929 2027-04-30 U-4217 Drug substance, Drug product 2013-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-002 7687052 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-002 8506929 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-003 7687052 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-003 8506929 2027-04-30 U-4217 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-004 7687052 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N202008-004 8506929 2027-04-30 U-4217 Drug substance, Drug product 2025-07-23 011fe1cb6892…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0002-1200 Amyvid Florbetapir F 18 Eli Lilly and Company NDA Current 0002-1200 Amyvid Florbetapir F 18 Eli Lilly and Company NDA Current 0002-1200 Amyvid Florbetapir F 18 Eli Lilly and Company NDA Current 0002-1200 Amyvid Florbetapir F 18 Eli Lilly and Company NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 83047 SUPPL 2025-08-05 83046 SUPPL 2025-08-05 83045 SUPPL 2025-08-05 82652 SUPPL 2025-06-24 82649 SUPPL 2025-06-24 61442 SUPPL 2019-12-26 61388 SUPPL 2019-12-23 19044 SUPPL 2013-12-17 9941 SUPPL 2013-12-16 43377 ORIG 2012-05-03 19043 ORIG 2012-04-09 32150 ORIG 2012-04-06